In a report released today, Patrick Sholl from Barrington maintained a Hold rating on CuriosityStream (CURI – Research Report). The company’s shares closed yesterday at $2.11. Effectively ...

Q1 2025 Revenue Guidance: Expected in the range of $14.5 to $15.5 million. CuriosityStream Inc (NASDAQ:CURI) achieved a significant year-over-year cash flow increase of $26 million in 2024.

Eli Lilly’s rising fortunes tied to its weight loss and diabetes drugs led to a nine-figure payday for its top executive — and covered an exclusive trip for leaders to attend last summer’s ...

CuriosityStream Inc. (CURI) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to loss of $0.09 per share a year ago.

This regularly scheduled sponsored column is written by Eli Tucker, Arlington-based Realtor and Arlington resident. If you would like to work with Eli and his team in Northern Virginia and the ...

Good afternoon. My name is Krista and I will be your conference operator today. I'd like to welcome everyone to the CuriosityStream Fourth Quarter and Full Year 2024 Earnings Conference Call ...

Eli Lilly stock has advanced more than 200% over the past three years thanks to the company’s dominance in the weight loss drug market. Lilly may face more competitors down the road in this high ...

That negative investor reaction was directed at companies involved in the white-hot weight loss drug segment of the market (Eli Lilly is the pharmaceutical giant behind a popular one, Zepbound).

WNBA. Caitlin Clark's new plan as leader in her second year at Indiana Fever will mean no one will be left out WNBA. Angel Reese gets fed up with so many lies about her and starts pointing the ...

$CURI insiders have traded $CURI stock on the open market 7 times in the past 6 months. Of those trades, 4 have been purchases and 3 have been sales.

CuriosityStream Inc.’s current stock price and volume Why CuriosityStream Inc.’s stock price changed recently Upgrades and downgrades for CURI from analysts CURI’s stock price momentum as measured by ...